Exosome achieves important milestone

Congratulations to Cambridge (US) based btov portfolio company, Exosome Diagnostics, for receiving a Current Procedural Terminology (CPT) Proprietary Laboratory Analyses (PLA) Code from the American Medical Association (AMA). Typically, it has taken similar tests 2-3 years to secure similar certifications but Exosome’s ExoDox Prostate(Intelliscore) test secured an issuance in just six months. This milestone sets the stage for obtaining broader coverage from private payors and Medicare reimbursement. For the offical press release, please click here.